Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
The zero based budgeting philosophy offers a fresh perspective on managing finances. Discover how it can transform your budgeting approach.
15,925 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
Oxford Square Capital trades at a 24% yield, yet a steep NAV decline and Q4 losses cast doubt on earnings durability....
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
Gemini Space Station stock has faced a sharp weekly drop as analysts trim targets after a mixed earnings update. This...
Schwab’s U.S. Dividend Equity ETF has a notable energy stake that’s helped its performance. This article explains wha...
Want to furnish on a budget without sacrificing style? This guide shares 10 practical tips to find tips best deals us...
Boomers face tighter retirement math as Social Security loses buying power and markets test savings. This report outl...